Alfa Chemistry Materials 5 - Products
Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
| Product | Description | |
|---|---|---|
| Heptakis(2,6-di-O-methyl)-β-cyclodextrin | Heptakis(2,6-di-O-methyl)-β-cyclodextrin. Group: Polysaccharide. CAS No. 51166-71-3. Product ID: (1S, 3R, 5R, 6S, 8R, 10R, 11S, 13R, 15R, 16S, 18R, 20R, 21S, 23R, 25R, 26S, 28R, 30R, 31S, 33R, 35R, 36S, 37R, 38S, 39R, 40S, 41R, 42S, 43R, 44S, 45R, 46S, 47R, 48S, 49R)-37, 39, 41, 43, 45, 47, 49-heptamethoxy-5, 10, 15, 20, 25, 30, 35-heptakis(methoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontane-36, 38, 40, 42, 44, 46, 48-heptol. Molecular formula: 1331.4g/mol. Mole weight: C56H98O35. COCC1C2C (C (C (O1)OC3C (OC (C (C3O)OC)OC4C (OC (C (C4O)OC)OC5C (OC (C (C5O)OC)OC6C (OC (C (C6O)OC)OC7C (OC (C (C7O)OC)OC8C (OC (O2)C (C8O)OC)COC)COC)COC)COC)COC)COC)OC)O. InChI=1S/C56H98O35/c1-64-15-22-36-29 (57)43 (71-8)50 (78-22)86-37-23 (16-65-2)80-52 (45 (73-10)30 (37)58)88-39-25 (18-67-4)82-54 (47 (75-12)32 (39)60)90-41-27 (20-69-6)84-56 (49 (77-14)34 (41)62)91-42-28 (21-70-7)83-55 (48 (76-13)35 (42)63)89-40-26 (19-68-5)81-53 (46 (74-11)33 (40)61)87-38-24 (17-66-3)79-51 (85-36)44 (72-9)31 (38)59/h22-63H, 15-21H2, 1-14H3/t22-, 23-, 24-, 25-, 26-, 27-, 28-, 29+, 30+, 31+, 32+, 33+, 34+, 35+, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43-, 44-, 45-, 46-, 47-, 48-, 49-, 50-, 51-, 52-, 53-, 54-, 55-, 56-/m1/s1. QGKBSGBYSPTPKJ-UZMKXNTCSA-N. |  |
| Heptylmagnesium Bromide (21% in Tetrahydrofuran, ca. 1mol/L) | Heptylmagnesium Bromide (21% in Tetrahydrofuran, ca. 1mol/L). Group: Solubility enhancing reagents. CAS No. 13125-66-1. Product ID: magnesium; heptane; bromide. Molecular formula: 203.4g/mol. Mole weight: C7H15BrMg. CCCCCC[CH2-].[Mg+2].[Br-]. InChI=1S/C7H15. BrH. Mg/c1-3-5-7-6-4-2; ; /h1, 3-7H2, 2H3; 1H; /q-1; ; +2/p-1. GRYDGXUVWLGHPL-UHFFFAOYSA-M. | |
| Hexadecylphosphonic acid | Hexadecylphosphonic acid. Group: Self-assembly materials self assembly and contact printing materials. CAS No. 4721-17-9. Product ID: hexadecylphosphonic acid. Molecular formula: 306.42g/mol. Mole weight: C16H35O3P. CCCCCCCCCCCCCCCCP(=O)(O)O. InChI= 1S / C16H35O3P / c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15- 16-20 (17, 18) 19 / h2-16H2, 1H3, (H2, 17, 18, 19). JDPSFRXPDJVJMV-UHFFFAOYSA-N. | |
| Hexaethylene glycol | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide)polymers. Alternative Names: 3,6,9,12,15-Pentaoxaheptadecane-1,17-diol. CAS No. 2615-15-8. Pack Sizes: Packaging 5, 25 g in poly bottle. Product ID: 2-[2-[2-[2-[2- (2-hydroxyethoxy) ethoxy]ethoxy]ethoxy]ethoxy]ethanol. Molecular formula: 282.33. Mole weight: C12H26O7. OCCOCCOCCOCCOCCOCCO. InChI= 1S / C12H26O7 / c13-1-3-15-5-7-17-9-11-19-12-10-18-8- 6-16-4-2-14 / h13-14H, 1-12H2. IIRDTKBZINWQAW | |
| Hexafluorocyclotriphosphazene | Hexafluorocyclotriphosphazene. Group: Battery materials electronic materials. CAS No. 15599-91-4. Pack Sizes: 5g. Product ID: 2,2,4,4,6,6-hexafluoro-1,3,5-triaza-2??5,4??5,6??5-triphosphacyclohexa-1,3,5-triene. Molecular formula: 248.93. Mole weight: F6N3P3. N1=P(N=P(N=P1(F)F)(F)F)(F)F. InChI=1S/F6N3P3/c1-10(2)7-11(3, 4)9-12(5, 6)8-10. DKQPXAWBVGCNHG-UHFFFAOYSA-N. >97.0%(GC). | |
| Hexakis (6-O-tertbutyl-dimethylsilyl)-α-cyclodextrin | Hexakis (6-O-tertbutyl-dimethylsilyl)-α-cyclodextrin. Group: Polysaccharide. | |
| Hexamethylbenzene Zone Refined (number of passes:20) | Hexamethylbenzene Zone Refined (number of passes:20). Group: other material building blocks. CAS No. 87-85-4. Product ID: 1,2,3,4,5,6-hexamethylbenzene. Molecular formula: 162.27g/mol. Mole weight: C12H18. CC1=C(C(=C(C(=C1C)C)C)C)C. InChI=1S/C12H18/c1-7-8 (2)10 (4)12 (6)11 (5)9 (7)3/h1-6H3. YUWFEBAXEOLKSG-UHFFFAOYSA-N. | |
| Hexamethylenedithiocarbamic Acid Hexamethyleneammonium Salt, ≥98% | Hexamethylenedithiocarbamic Acid Hexamethyleneammonium Salt, ≥98%. Group: other glass and ceramic materials. CAS No. 2608-11-9. Product ID: azepane; azepane-1-carbodithioic acid. Molecular formula: 274.5g/mol. Mole weight: C13H26N2S2. C1CCCNCC1.C1CCCN(CC1)C(=S)S. InChI=1S/C7H13NS2. C6H13N/c9-7(10)8-5-3-1-2-4-6-8; 1-2-4-6-7-5-3-1/h1-6H2, (H, 9, 10); 7H, 1-6H2. CIPHOUPBLAOEKY-UHFFFAOYSA-N. | |
| Hexanoic acid | Caproic acid is derived from the crude fermentation of butyric acid; or by fractional distillation of natural fatty acids. Used in various flavorings; manufacture of rubber chemicals; varnish dryers; resins; pharmaceuticals. Group: Solubility enhancing reagents. Alternative Names: Caproic acid. CAS No. 142-62-1. Pack Sizes: 25 kg/DRUMS. Product ID: hexanoic acid. Molecular formula: 116.16g/mol. Mole weight: C6H12O2. CCCCCC(=O)O. InChI=1S/C6H12O2/c1-2-3-4-5-6 (7)8/h2-5H2, 1H3, (H, 7, 8). FUZZWVXGSFPDMH-UHFFFAOYSA-N. 99%+. | |
| Hexaphenylbenzene | Hexaphenylbenzene. Group: Small molecule semiconductor building blockscarbon nano materials dendrimer building blocks. CAS No. 992-04-1. Product ID: 1,2,3,4,5,6-hexakis-phenylbenzene. Molecular formula: 534.7g/mol. Mole weight: C42H30. C1=CC=C (C=C1) C2=C (C (=C (C (=C2C3=CC=CC=C3) C4=CC=CC=C4) C5=CC=CC=C5) C6=CC=CC=C6) C7=CC=CC=C7. InChI=1S/C42H30/c1-7-19-31 (20-8-1)37-38 (32-21-9-2-10-22-32)40 (34-25-13-4-14-26-34)42 (36-29-17-6-18-30-36)41 (35-27-15-5-16-28-35)39 (37)33-23-11-3-12-24-33/h1-30H. QBHWPVJPWQGYDS-UHFFFAOYSA-N. | |
| Hexylamine Hydrobromide, ≥98% | Hexylamine Hydrobromide, ≥98%. Group: Electronic chemicals. CAS No. 7334-95-4. Product ID: hexan-1-amine; hydrobromide. Molecular formula: 182.1g/mol. Mole weight: C6H16BrN. CCCCCCN.Br. InChI=1S/C6H15N.BrH/c1-2-3-4-5-6-7; /h2-7H2, 1H3; 1H. ZLSVALLKHLKICA-UHFFFAOYSA-N. | |
| Hexylmagnesium Bromide (20% in Tetrahydrofuran, ca. 1mol/L) | Hexylmagnesium Bromide (20% in Tetrahydrofuran, ca. 1mol/L). Group: Solubility enhancing reagents. CAS No. 3761-92-0. Product ID: magnesium; hexane; bromide. Molecular formula: 189.38g/mol. Mole weight: C6H13BrMg. CCCCC[CH2-].[Mg+2].[Br-]. InChI=1S/C6H13.BrH.Mg/c1-3-5-6-4-2; ; /h1, 3-6H2, 2H3; 1H; /q-1; ; +2/p-1. LZFCBBSYZJPPIV-UHFFFAOYSA-M. | |
| Hexyl Mercaptan | N-hexanethiol is a colorless liquid with an unpleasant odor. Mp: -81°C; bp: 152-153°C. Density 0.838 g cm-3 (at 25°C).;Liquid;COLOURLESS LIQUID WITH CHARACTERISTIC ODOUR.;colourless liquid with earthy odour;Colorless liquid with an unpleasant odor. Group: Solubility enhancing reagents self assembly and contact printing materials. CAS No. 111-31-9. Product ID: hexane-1-thiol. Molecular formula: 118.24g/mol. Mole weight: C6H14S;CH3(CH2)5SH;C6H14S. CCCCCCS. InChI=1S/C6H14S/c1-2-3-4-5-6-7/h7H, 2-6H2, 1H3. PMBXCGGQNSVESQ-UHFFFAOYSA-N. | |
| Hexylphosphonic acid | Hexylphosphonic acid. Group: Self-assembly materials self assembly and contact printing materials. CAS No. 4721-24-8. Product ID: hexylphosphonic acid. Molecular formula: 166.16g/mol. Mole weight: C6H15O3P. CCCCCCP(=O)(O)O. InChI=1S/C6H15O3P/c1-2-3-4-5-6-10(7, 8)9/h2-6H2, 1H3, (H2, 7, 8, 9). GJWAEWLHSDGBGG-UHFFFAOYSA-N. | |
| Hexyltrimethoxysilane | Liquid. Group: Silane coupling agentsself assembly and contact printing materials. Alternative Names: n-Hexyltrimethoxysilane. CAS No. 3069-19-0. Pack Sizes: 10 g; 100 g. Product ID: hexyl(trimethoxy)silane. Molecular formula: 206.35. Mole weight: C9H22O3Si. CCCCCC[Si](OC)(OC)OC. InChI=1S/C9H22O3Si/c1-5-6-7-8-9-13 (10-2, 11-3)12-4/h5-9H2, 1-4H3. CZWLNMOIEMTDJY-UHFFFAOYSA-N. 95%. | |
| Highly Oriented Pyrolytic Graphite (HOPG-Grade A) | Carbon black oil appears as a dark colored liquid with a petroleum-like odor. Less dense than water and insoluble in water. Vapors heavier than air.;Carbon, activated is a black grains that have been treated to improve absorptive ability. May heat spontaneously if not properly cooled after manufacture.;Carbon, animal or vegetable origin appears as a black powder or granular mixed with a tar or starch and water binder pressed into regular lumps or briquettes. Heats slowly and ignites in air especially if wet.;Graphite (natural) appears as a mineral form of the element carbon. Hexagonal crystals or thin leaf-like layers. Steel-gray to black with a metallic luster and a greasy feel. An electrical conductor. Used for high-temperature crucibles, as a lubricant and in "lead" pencils.;DryPowder; DryPowder, Liquid; DryPowder, PelletsLargeCrystals; DryPowder, PelletsLargeCrystals, WetSolid, OtherSolid, Liquid; DryPowder, WetSolid, Liquid; Liquid; OtherSolid; OtherSolid, GasVapor, Liquid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid, Liquid; WetSolid; WetSolid, Liquid;OtherSolid; PelletsLargeCrystals;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid; WetSolid;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; DryPowder, WetSolid; Liquid; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystal | |
| Highly Oriented Pyrolytic Graphite (HOPG-Grade B) | Carbon black oil appears as a dark colored liquid with a petroleum-like odor. Less dense than water and insoluble in water. Vapors heavier than air.;Carbon, activated is a black grains that have been treated to improve absorptive ability. May heat spontaneously if not properly cooled after manufacture.;Carbon, animal or vegetable origin appears as a black powder or granular mixed with a tar or starch and water binder pressed into regular lumps or briquettes. Heats slowly and ignites in air especially if wet.;Graphite (natural) appears as a mineral form of the element carbon. Hexagonal crystals or thin leaf-like layers. Steel-gray to black with a metallic luster and a greasy feel. An electrical conductor. Used for high-temperature crucibles, as a lubricant and in "lead" pencils.;DryPowder; DryPowder, Liquid; DryPowder, PelletsLargeCrystals; DryPowder, PelletsLargeCrystals, WetSolid, OtherSolid, Liquid; DryPowder, WetSolid, Liquid; Liquid; OtherSolid; OtherSolid, GasVapor, Liquid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid, Liquid; WetSolid; WetSolid, Liquid;OtherSolid; PelletsLargeCrystals;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid; WetSolid;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; DryPowder, WetSolid; Liquid; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystal | |
| Highly Oriented Pyrolytic Graphite (HOPG-Grade C) | Carbon black oil appears as a dark colored liquid with a petroleum-like odor. Less dense than water and insoluble in water. Vapors heavier than air.;Carbon, activated is a black grains that have been treated to improve absorptive ability. May heat spontaneously if not properly cooled after manufacture.;Carbon, animal or vegetable origin appears as a black powder or granular mixed with a tar or starch and water binder pressed into regular lumps or briquettes. Heats slowly and ignites in air especially if wet.;Graphite (natural) appears as a mineral form of the element carbon. Hexagonal crystals or thin leaf-like layers. Steel-gray to black with a metallic luster and a greasy feel. An electrical conductor. Used for high-temperature crucibles, as a lubricant and in "lead" pencils.;DryPowder; DryPowder, Liquid; DryPowder, PelletsLargeCrystals; DryPowder, PelletsLargeCrystals, WetSolid, OtherSolid, Liquid; DryPowder, WetSolid, Liquid; Liquid; OtherSolid; OtherSolid, GasVapor, Liquid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid, Liquid; WetSolid; WetSolid, Liquid;OtherSolid; PelletsLargeCrystals;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystals, OtherSolid; WetSolid;DryPowder; DryPowder, OtherSolid; DryPowder, PelletsLargeCrystals; DryPowder, WetSolid; Liquid; OtherSolid; PelletsLargeCrystals; PelletsLargeCrystal | |
| High Purified Carboxylic Single-walled carbon nanotubes (SWCNTS-COOH), >95%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, -COOH:~9.0wt% | High Purified Carboxylic Single-walled carbon nanotubes (SWCNTS-COOH), >95%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, -COOH:~9.0wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| High Purified Hydroxylate Single-walled carbon nanotubes (SWCNTS-OH), >95%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, OH:~7.0wt% | High Purified Hydroxylate Single-walled carbon nanotubes (SWCNTS-OH), >95%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, OH:~7.0wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| High speed bright copper electroplating solution | High speed bright copper electroplating solution. Group: Electronic materials. | |
| High Surface Area Graphene Oxide | High Surface Area Graphene Oxide. Group: Graphenes. | |
| HMWCNT Type1- Carbon Nanotubes Multi Walled Helical | HMWCNT Type1- Carbon Nanotubes Multi Walled Helical. Group: Nanotubes. CAS No. 308068-56-6. | |
| Hollow carbon nanospheres | Hollow carbon nanospheres. Group: Carbon nano materials. | |
| HO-PEG12-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| HO-PEG12-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| HO-PEG12-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: S may include: bioconjugation, drug delivery, peg hydrogel, crosslinker, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Dodecaethylene glycol. Product ID: 2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (2-hydroxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanol. Molecular formula: 546.6g/mol. Mole weight: C24H50O13. [H]OCCO. 1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2. LYCAIKOWRPUZTN-UHFFFAOYSA-N. | |
| HO-PEG12-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| HO-PEG1K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: hydroxyl-PEG-Amine, HO-PEG-NH2, HO-PEG-NH2. Molecular formula: average Mn 1000. | |
| HO-PEG20K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: hydroxyl-PEG-Amine, HO-PEG-NH2, HO-PEG-NH2. Molecular formula: average Mn 20000. | |
| HO-PEG4-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| HO-PEG4-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: HO-PEG4-PA. Product ID: 3-(2-hydroxyethoxy)propanoic acid. Molecular formula: 134.13g/mol. Mole weight: C5H10O4. OCCOCCC(O)=O. 1S/C5H10O4/c6-2-4-9-3-1-5(7)8/h6H, 1-4H2, (H, 7, 8). GTIFLSYPOXYYFG-UHFFFAOYSA-N. | |
| HO-PEG5K-NHS | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Hydroxyl-PEG-NHS Ester, HO-PEG-NHS. Molecular formula: average Mn 5000. | |
| HO-PEG8-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Group: Poly(ethylene glycol) and poly(ethylene oxide). ≥ 95% (1H-NMR). Product conforms to structure by 1H-NMR. | |
| HO-PEG8-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 2- [2- [2- [2- [2- [2- [2- (2-hydroxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethanol. Molecular formula: 370.44g/mol. Mole weight: C16H34O9. C(COCCOCCOCCOCCOCCOCCOCCO)O. InChI= 1S / C16H34O9 / c17-1-3-19-5-7-21-9-11-23-13-15-25-16 -14-24-12-10-22-8-6-20-4-2-18 / h17-18H, 1-16H2. GLZWNFNQMJAZGY-UHFFFAOYSA-N. | |
| HO-PEG8-Propionic acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and redu. Group: Poly(ethylene glycol) and poly(ethylene oxide). Product ID: 3- [2- [2- [2- [2- [2- [2- [2- (2-hydroxyethoxy) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoic acid. Molecular formula: 442.5g/mol. Mole weight: C19H38O11. C(COCCOCCOCCOCCOCCOCCOCCOCCO)C(=O)O. InChI= 1S / C19H38O11 / c20-2-4-24-6-8-26-10-12-28-14-16-30-1 8-17-29-15-13-27-11-9-25-7-5-23-3-1-1 9 (21) 22 / h20H, 1-18H2, (H, 21, 22). BGBLNDCLYGWOKM-UHFFFAOYSA-N | |
| HS-PEG1500-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: HS-PEG-SH, Thiol-PEG-Thiol. Molecular formula: average Mn 1,500. | |
| HS-PEG2K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: HS-PEG-NH2. Molecular formula: average Mn 2000. | |
| HS-PEG3500-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: HS-PEG-NH2. Molecular formula: average Mn 3500. | |
| HS-PEG5K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: HS-PEG-NH2. Molecular formula: average Mn 5000. | |
| HS-PEG7500-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Thiol-PEG-Carboxyl, HS-PEG-COOH, HS-PEG-COOH. Molecular formula: average Mn 7,500. | |
| HS-PEG7500-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: HS-PEG-NH2. Molecular formula: average Mn 7,500. | |
| Hyaluronan biotin sodium salt | Hyaluronan biotin sodium salt. Group: Polysaccharide. | |
| Hydrotalcite, synthetic | Hydrotalcite, synthetic. Group: other glass and ceramic materials. CAS No. 12304-65-3. | |
| Hydroxyapatite | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Biocompatible ceramicsnanoparticles. CAS No. 1306-06-5. Pack Sizes: 200 kg. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca2HO5P. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxyapatite | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Biocompatible ceramicsnanoparticles. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxyapatite Micronpowder | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Nanopowders. CAS No. 12167-74-7. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxyapatite Microspheres | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Biocompatible ceramics. CAS No. 1306-06-5. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxyapatite Nanopowder | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Nanopowders. CAS No. 12167-74-7. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxychloroquine sulfate, 98% | Hydroxychloroquine sulfate, 98%. Group: other glass and ceramic materials. CAS No. 747-36-4. Product ID: 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol; sulfuric acid. Molecular formula: 434g/mol. Mole weight: C18H28ClN3O5S. CCN (CCCC (C)NC1=C2C=CC (=CC2=NC=C1)Cl)CCO. OS (=O) (=O)O. InChI=1S/C18H26ClN3O. H2O4S/c1-3-22 (11-12-23)10-4-5-14 (2)21-17-8-9-20-18-13-15 (19)6-7-16 (17)18; 1-5 (2, 3)4/h6-9, 13-14, 23H, 3-5, 10-12H2, 1-2H3, (H, 20, 21); (H2, 1, 2, 3, 4). JCBIVZZPXRZKTI-UHFFFAOYSA-N. | |
| Hydroxy Double-Walled Crabon Nanotubes, >60%, ID:1-3nm, OD:2-4nm, Length:~50μm, -OH:~3wt% | Hydroxy Double-Walled Crabon Nanotubes, >60%, ID:1-3nm, OD:2-4nm, Length:~50μm, -OH:~3wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxy Double-Walled Crabon Nanotubes (DWNTs-OH), >60%, ID:1-3nm, OD:2-4nm, Length:0.5-2μm, -OH:~2.9wt% | Hydroxy Double-Walled Crabon Nanotubes (DWNTs-OH), >60%, ID:1-3nm, OD:2-4nm, Length:0.5-2μm, -OH:~2.9wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxyethyl-cellulose | WHITE POWDER. Group: Polysaccharide. CAS No. 9004-62-0. Product ID: 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol. Molecular formula: 736.7g/mol. Mole weight: (C2H602)x;C29H52O21. CC1C (C (C (C (O1)CO)OC2C (C (C (C (O2)COC3C (C (C (C (O3)CO)OC)O)O)OC4C (C (C (C (O4)CO)OC)O)OCCO)O)O)O)O. InChI=1S/C29H52O21/c1-10-15 (34)16 (35)24 (13 (8-33)45-10)49-28-20 (39)18 (37)25 (50-29-26 (43-5-4-30)21 (40)23 (42-3)12 (7-32)47-29)14 (48-28)9-44-27-19 (38)17 (36)22 (41-2)11 (6-31)46-27/h10-40H, 4-9H2, 1-3H3. CWSZBVAUYPTXTG-UHFFFAOYSA-N. | |
| Hydroxyethylcellulose ethoxylate, quaternized | Hydroxyethyl cellulose is a white or light yellow, odorless, non-toxic fibrous or powdery solid, prepared by etherification of alkaline cellulose and ethylene oxide (or chloroethanol), and is a non-ionic type Soluble cellulose ethers. Group: Natural polymers and biopolymers. Alternative Names: Polyquaternium 10. CAS No. 68610-92-4. | |
| Hydroxyethyl starch | Hydroxyethyl starch. Group: Polysaccharide. CAS No. 9005-27-0. Product ID: (2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; 2-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol. Molecular formula: 580.6g/mol. Mole weight: C22H44O17. C (COCC1C (C (C (C (O1)OCCO)OCCO)OCCO)OCCO)O. C (C1C (C (C (C (O1)O)O)O)O)O. InChI=1S/C16H32O11. C6H12O6/c17-1-6-22-11-12-13 (23-7-2-18)14 (24-8-3-19)15 (25-9-4-20)16 (27-12)26-10-5-21; 7-1-2-3 (8)4 (9)5 (10)6 (11)12-2/h12-21H, 1-11H2; 2-11H, 1H2/t12-, 13-, 14+, 15-, 16+; 2-, 3-, 4+, 5-, 6+/m11/s1. DNZMDASEFMLYBU-RNBXVSKKSA-N. | |
| Hydroxylapatite | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Biocompatible ceramics. CAS No. 1306-06-5. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxylapatite, | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Biocompatible ceramics. CAS No. 1306-06-5. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxylapatite, 97% | DryPowder; Liquid; OtherSolid; PelletsLargeCrystals. Group: Biocompatible ceramics. CAS No. 1306-06-5. Product ID: pentacalcium; hydroxide; triphosphate. Molecular formula: 502.3g/mol. Mole weight: Ca5(PO4)3(OH);Ca5HO13P3. [OH-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [O-]P(=O)([O-])[O-]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. [Ca+2]. InChI=1S/5Ca.3H3O4P.H2O/c; ; ; ; ; 3*1-5(2, 3)4; /h; ; ; ; ; 3*(H3, 1, 2, 3, 4); 1H2/q5*+2; ; ; ; /p-10. XYJRXVWERLGGKC-UHFFFAOYSA-D. | |
| Hydroxylation Multi-walled Carbon nanotube,double open, ≥95%, ID:3-5nm, OD:8-15nm, Length:0.2-2um, -OH:≥3.7wt% | Hydroxylation Multi-walled Carbon nanotube,double open, ≥95%, ID:3-5nm, OD:8-15nm, Length:0.2-2um, -OH:≥3.7wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxyl Functionalized Graphene | Hydroxyl Functionalized Graphene. Group: Graphenes. | |
| Hydroxy Multi-Walled Carbon Nanotubes, >95%,ID:3-5nm,OD:8-15nm,Length: ~50μm,-OH:~3.7wt% | Hydroxy Multi-Walled Carbon Nanotubes, >95%,ID:3-5nm,OD:8-15nm,Length: ~50μm,-OH:~3.7wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxypropyl-β-cyclodextrin | DryPowder; Liquid. Group: Supramolecular host materials. CAS No. 128446-35-5. Pack Sizes: 25 kg. Product ID: (1R, 3S, 5S, 6R, 8S, 10S, 11R, 13S, 15S, 16R, 18S, 20S, 21R, 23S, 25S, 26R, 28S, 30S, 31R, 33S, 35S, 36S, 37S, 38S, 39S, 40S, 41S, 42S, 43S, 44S, 45S, 46S, 47S, 48S, 49S)-5, 10, 15, 20, 25, 30, 35-heptakis(2-hydroxypropoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontane-36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49-tetradecol. Molecular formula: 1541.5g/mol. Mole weight: C63H112O42. CC (COCC1C2C (C (C (O1)OC3C (OC (C (C3O)O)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (O2)C (C8O)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)O)O)O. InChI=1S/C63H112O42/c1-22 (64)8-85-15-29-50-36 (71)43 (78)57 (92-29)100-51-30 (16-86-9-23 (2)65)94-59 (45 (80)38 (51)73)102-53-32 (18-88-11-25 (4)67)96-61 (47 (82)40 (53)75)104-55-34 (20-90-13-27 (6)69)98-63 (49 (84)42 (55)77)105-56-35 (21-91-14-28 (7)70)97-62 (48 (83)41 (56)76)103-54-33 (19-89-12-26 (5)68)95-60 (46 (81)39 (54)74)101-52-31 (17-87-10-24 (3)66)93-58 (99-50)44 (79)37 (52)72/h22-84H, 8-21H2, 1-7H3/t22?, 23?, 24?, 25?, 26?, 27?, 28?, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43-, 44-, 45-, 46-, 47-, 48-, 49-, 50-, 51-, 52-, 53-, 54-, 55-, 56-, 57-, 58-, 59-, 60-, 61-, | |
| Hydroxypropyl-beta-cyclodextrin | DryPowder; Liquid. Group: Macrocycles. CAS No. 128446-35-5. Product ID: (1R, 3S, 5S, 6R, 8S, 10S, 11R, 13S, 15S, 16R, 18S, 20S, 21R, 23S, 25S, 26R, 28S, 30S, 31R, 33S, 35S, 36S, 37S, 38S, 39S, 40S, 41S, 42S, 43S, 44S, 45S, 46S, 47S, 48S, 49S)-5, 10, 15, 20, 25, 30, 35-heptakis(2-hydroxypropoxymethyl)-2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontane-36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49-tetradecol. Molecular formula: 1541.5g/mol. Mole weight: C63H112O42. CC (COCC1C2C (C (C (O1)OC3C (OC (C (C3O)O)OC4C (OC (C (C4O)O)OC5C (OC (C (C5O)O)OC6C (OC (C (C6O)O)OC7C (OC (C (C7O)O)OC8C (OC (O2)C (C8O)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)COCC (C)O)O)O)O. InChI=1S/C63H112O42/c1-22 (64)8-85-15-29-50-36 (71)43 (78)57 (92-29)100-51-30 (16-86-9-23 (2)65)94-59 (45 (80)38 (51)73)102-53-32 (18-88-11-25 (4)67)96-61 (47 (82)40 (53)75)104-55-34 (20-90-13-27 (6)69)98-63 (49 (84)42 (55)77)105-56-35 (21-91-14-28 (7)70)97-62 (48 (83)41 (56)76)103-54-33 (19-89-12-26 (5)68)95-60 (46 (81)39 (54)74)101-52-31 (17-87-10-24 (3)66)93-58 (99-50)44 (79)37 (52)72/h22-84H, 8-21H2, 1-7H3/t22?, 23?, 24?, 25?, 26?, 27?, 28?, 29-, 30-, 31-, 32-, 33-, 34-, 35-, 36-, 37-, 38-, 39-, 40-, 41-, 42-, 43-, 44-, 45-, 46-, 47-, 48-, 49-, 50-, 51-, 52-, 53-, 54-, 55-, 56-, 57-, 58-, 59-, 60-, 61-, 62-, 63-/m0/s1. ODLHGICHYURWBS-FOSILIAI | |
| (Hydroxypropyl)methyl cellulose | (Hydroxypropyl)methyl cellulose. Group: Natural polymers and biopolymerspolysaccharide. CAS No. 9004-65-3. | |
| Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:2-5nm, OD:<8nm, Length:10-30μm, -OH:~5.6wt% | Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:2-5nm, OD:<8nm, Length:10-30μm, -OH:~5.6wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-10nm, OD:10-20nm, Length:10-30μm, -OH:~3.1wt% | Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-10nm, OD:10-20nm, Length:10-30μm, -OH:~3.1wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-10nm, OD:20-30nm, Length:10-30μm, -OH:~1.8wt% | Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-10nm, OD:20-30nm, Length:10-30μm, -OH:~1.8wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-12nm, OD:30-50nm, Length:10-20μm, -OH:~1.1wt% | Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-12nm, OD:30-50nm, Length:10-20μm, -OH:~1.1wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-15nm, OD:>50nm, Length:10-20μm, -OH:~0.71wt% | Hydroxy Purified Multi-walled carbon nanotubes, >95%, ID:5-15nm, OD:>50nm, Length:10-20μm, -OH:~0.71wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
| Hydroxy Purified Single-walled carbon nanotubes, >90%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, -OH:~4wt% | Hydroxy Purified Single-walled carbon nanotubes, >90%, ID:0.8-1.6nm, OD:1-2nm, Length:5-30μm, -OH:~4wt%. Group: Carbon nano materials. CAS No. 308068-56-6. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.